Our Mission:

to set the global standard in the management of provenance and integrity of biological assets while biosafety and biosecurity underpin all of our activities.

We are driven each day to ensure the potential of synthetic biology is realised worldwide. Our diverse team of experts is dedicated to advancing the potential of synthetic biology and engineering biology worldwide by securing the supply chain of engineered biological assets.

We pioneer innovations that enhance the integrity and traceability of engineered biological assets through our proprietary DNA signature technology. 

Our diverse team of experts is dedicated to advancing the potential of synthetic biology and engineering biology worldwide by securing the supply chain of engineered biological assets.

Our Mission

At GitLife Biotech, our mission is to set the global standard in the management of provenance and integrity of biological assets while biosafety and biosecurity underpin all of our activities.
We are driven each day to ensure the potential of synthetic biology is realised worldwide.

Our Vision

Our vision is to enable the global community to safely and seamlessly develop, commercialise, deploy and trace engineered biological assets.

our story, so far...

GitLife Biotech’s journey has been marked by numerous exciting milestones that reflect our commitment to innovation, excellence, and collaboration.

From our incorporation to securing prestigious grants and forming valuable partnerships, our timeline highlights the rapid growth and significant achievements that have shaped our story.

Click around below to learn more about our journey so far and key milestones.

Yet, this is just the beginning. We are enthusiastic about the future and are driven by our commitment to establishing ourselves as the global leader in management of biological asset provenance and integrity. Our objective is to enhance transparency, which is crucial for advancing engineering biology and managing intellectual property rights.

meet the gitLife team.

At GitLife Biotech, our team is made up of leading experts in synthetic biology, life sciences and digital technologies. With varied backgrounds and extensive expertise, our scientists drive innovation dedicated to advancing the global standards of cell engineering, cell editing, and bio-asset management.

Alastair Orr Ewing

Chief Executive Officer

Leanne Hobbs

Chief Digital Officer

Natalio Krasnogor

Chief Technical Officer

Nadia Rostami

Chief Scientific Officer

Saransh Saxena

Bioinformatician

Gilly Wang

Molecular Microbiologist

Annunziata Lopiccolo

Technical Lead

Benjamin Hastings

Lab Automation Lead

our technologies

Cell and Biological Assets Engineering with Version Control

CellRepo™ is our revolutionary platform that brings version control to engineering biology. This advanced system meticulously logs each modification. For example, microbial strains and plasmids can be tracked, ensuring complete traceability and management of biological assets.
With our proprietary GenoSignature® technology, every genetic change is recorded and easily retrievable, supporting robust and transparent research.

Technology: Ensuring Provenance and Integrity

GenoSignature® molecular technology is a unique feature of GitLife Biotech’s offerings. It provides a detailed history of genetic modifications, enhancing transparency and reliability in synthetic biology. This technology is critical for ensuring the integrity of biological materials and supporting robust genetic research.

GenoStamps™ are unique, biological signatures that are inserted into the biological asset at a specific and easily identifiable location, to avoid misidentification and provide traceability during the engineering and optimisation of the biological asset.
GenoGuards ™ are also unique, biological signatures that are inserted into the biological asset but in a covert and undisclosed location. These signatures establish a link between the biological asset and its owner, ensuring secure identification and ownership verification for our customer based on proprietary technology.

making an impact

At GitLife Biotech, we seek to revolutionise the way the synthetic biology industry designs, develops and deploys engineered biological assets.

Our biosecurity products enable robust rights management, traceability and transparency, empowering confident distribution and manufacturing with clear ownership and accountability. Our innovative technologies and solutions are designed to address some of the world’s most pressing challenges, from industrial biotechnology, to healthcare, agriculture to environmental protection and bioenergy. By making a significant impact in these fields, we aim to establish a sustainable future.

contact us

Connect with us to explore our innovative solutions in cell engineering and genetic modification. Whether you’re interested in our cutting-edge CellRepo™ platform, or our GenoSignature® technology, our team is here to support your research and development projects through effective biological asset management solutions.

Careers: Our Current vacancies.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

If there is no suitable role listed above, but you’d like to be considered for future vacancies, we’d love to hear from you!